Scott A. Gangloff, Chief Technology Officer at Akero Therapeutics, Inc. (AKRO), sold 848 shares at $54.84 ($47K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
Open-market sale of $47k AKRO by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.